Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cyclosporine A formulation affects its ocular distribution in rabbits.

Literature DB >> 11837694

Cyclosporine A formulation affects its ocular distribution in rabbits.

Mitsuaki Kuwano¹, Hajime Ibuki, Nobuo Morikawa, Atsutoshi Ota, Yoichi Kawashima.

Abstract

Entities: Chemical Species

Mesh：

Substances：

Year: 2002 PMID： 11837694 DOI： 10.1023/a:1013671819604

Source DB: PubMed Journal: Pharm Res ISSN： 0724-8741 Impact factor: 4.200

× No keyword cloud information.

5 in total

1. Effect of cyclosporine A formulations on bovine corneal absorption: ex-vivo study.

Authors: C A Le Bourlais; F Chevanne; B Turlin; L Acar; H Zia; P A Sado; T E Needham; R Leverge
Journal: J Microencapsul Date: 1997 Jul-Aug Impact factor: 3.142

2. Ocular absorption of cyclosporine A from liposomes incorporated into collagen shields.

Authors: U Pleyer; B Elkins; D Rückert; S Lutz; J Grammer; J Chou; K H Schmidt; B J Mondino
Journal: Curr Eye Res Date: 1994-03 Impact factor: 2.424

3. Topical Cyclosporine A in the management of postkeratoplasty glaucoma and corticosteroid-induced ocular hypertension (CIOH) and the penetration of topical 0.5% cyclosporine A into the cornea and anterior chamber.

Authors: H D Perry; E D Donnenfeld; A Acheampong; A J Kanellopoulos; P D Sforza; G D'Aversa; A Wallerstein; M Stern
Journal: CLAO J Date: 1998-07

4. Penetration of cyclosporin A into the rabbit cornea and aqueous humor after topical drop and collagen shield administration.

Authors: A Kanpolat; F Batioglu; M Yilmaz; F Akbas
Journal: CLAO J Date: 1994-04

5. Ocular penetration of cyclosporine A in the rat eye.

Authors: D BenEzra; G Maftzir
Journal: Arch Ophthalmol Date: 1990-04

5 in total

12 in total

1. Novel Nanomicellar Formulation Approaches for Anterior and Posterior Segment Ocular Drug Delivery.

Authors: Kishore Cholkar; Ashaben Patel; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal: Recent Pat Nanomed Date: 2012

Review 2. Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis.

Authors: Pakit Vichyanond; Panida Kosrirukvongs
Journal: Curr Allergy Asthma Rep Date: 2013-06 Impact factor: 4.806

Review 3. Controlled ocular drug delivery with nanomicelles.

Authors: Ravi D Vaishya; Varun Khurana; Sulabh Patel; Ashim K Mitra
Journal: Wiley Interdiscip Rev Nanomed Nanobiotechnol Date: 2014-06-02

Review 4. An overview on dry eye treatment: approaches for cyclosporin a delivery.

Authors: Burçin Yavuz; Sibel Bozdağ Pehlivan; Nurşen Unlü
Journal: ScientificWorldJournal Date: 2012-04-24

Review 5. Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases.

Authors: Rinda Devi Bachu; Pallabitha Chowdhury; Zahraa H F Al-Saedi; Pradeep K Karla; Sai H S Boddu
Journal: Pharmaceutics Date: 2018-02-27 Impact factor: 6.321

6. Stability, safety, and transcorneal mechanistic studies of ophthalmic lyophilized cyclosporine-loaded polymeric micelles.

Authors: Yan Shen; Yinglan Yu; Birendra Chaurasiya; Xiaolian Li; Ying Xu; Thomas J Webster; Jiasheng Tu; Runing Sun
Journal: Int J Nanomedicine Date: 2018-12-05

7. Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and Phase 3 Studies.

Authors: Ranjan Malhotra; Douglas K Devries; Jodi Luchs; Alan Kabat; Barry A Schechter; Bridgitte Shen Lee; Lee Shettle; Robert Smyth-Medina; Abayomi Ogundele; Charles Darby; Jason Bacharach; Paul Karpecki
Journal: Cornea Date: 2019-10 Impact factor: 2.651